Results 111 to 120 of about 2,895 (221)
What Is Your Diagnosis? Splenic Mass in an African Pygmy Hedgehog
Veterinary Clinical Pathology, EarlyView.
Gabriela Hartmann +6 more
wiley +1 more source
Cancer Reports, Volume 9, Issue 3, March 2026.ABSTRACT Background Myeloid sarcoma is a rare solid tumour of immature myeloid precursors occurring in an extramedullary site. It often presents significant diagnostic and therapeutic challenges to clinical haematologists. Case We describe a previously healthy patient who presented simultaneously with hyperleucocytic chronic myeloid leukaemia in ...
Kar Ying Yong +3 more
wiley +1 more source
What's Your Diagnosis? A Case of Extreme Thrombocytosis in a Dog
Veterinary Clinical Pathology, EarlyView.
Stephanie F. Anderson +5 more
wiley +1 more source
HemaSphere, Volume 10, Issue 3, March 2026.Abstract TP53 mutations are found in over 50% of tumor types, including myeloproliferative neoplasms (MPNs). MPNs are characterized by a chronic phase, which may progress to secondary acute myeloid leukemia (sAML). Here, we discuss the physiological functions of p53 in hematopoiesis and its deregulation in MPNs.
Suzana da Silva‐Benedito +6 more
wiley +1 more source
Hematological Oncology, Volume 44, Issue 2, March 2026.ABSTRACT Post‐transplant lymphoproliferative disorder (PTLD) is a rare, dreaded complication of organ transplantation with major clinical challenges. We conducted a nationwide population‐based study of all solid organ transplant (SOT) recipients (n = 6555), both adults and children, over a 30‐year period in Finland.
Terhi K. Friman +11 more
wiley +1 more source
TREATMENT OF MYELOFIBROSIS: PRESENT AND FUTURE
Hematology, Transfusion and Cell TherapyPrimary myelofibrosis (PMF) is a myeloproliferative neoplasm characterised by stem cell-derived clonal myeloproliferation often, but not always, accompanied by JAK2, CALR or MPL mutations.
Birsen Sahip Yesiralioğlu
doaj +1 more source
Research opportunities in loss of red blood cell mass in space flight [PDF]
Decreases of red blood cell mass and plasma volume have been observed consistently following manned space flights. Losses of red cell mass by United States astronauts have averaged 10 to 15% (range: 2 to 21%).
Fisher, K. D., Talbot, J. M.
core +1 more source
Assessing The Role of Spleen in Development of Myeloid Bias Amongst Haematopoietic Stem Cells [PDF]
Myeloproliferative disorders are common in aged individuals, and ageing is associated with a skewing of haematopoiesis towards myeloid lineage. The spleen houses a distinct resident population of HSC primed for myelopoiesis which retain this myeloid bias
O'Neill, Helen C +2 more
core +1 more source
Hematological Oncology, Volume 44, Issue 2, March 2026.ABSTRACT Myelofibrosis is characterized by perturbation of the JAK/STAT pathway and upregulation of anti‐apoptotic factors leading to myeloproliferation, bone marrow fibrosis (BMF), extramedullary hematopoiesis, splenomegaly, and cytopenias.
Francesco Passamonti +16 more
wiley +1 more source
Med Research, Volume 2, Issue 1, Page 75-88, March 2026.Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu +8 more
wiley +1 more source